Multiple myeloma

PET Clin. 2015 Apr;10(2):227-41. doi: 10.1016/j.cpet.2014.12.008. Epub 2015 Jan 24.

Abstract

This article presents a review of multiple myeloma, precursor states, and related plasma cell disorders. The clinical roles of fluorodeoxyglucose PET/computed tomography (CT) and the potential to improve the management of patients with multiple myeloma are discussed. The clinical and research data supporting the utility of PET/CT use in evaluating myeloma and other plasma cell dyscrasias continues to grow.

Keywords: Fluorodeoxyglucose; Monoclonal gammopathy; Multiple myeloma; PET; PET/CT; Plasmacytoma.

Publication types

  • Review

MeSH terms

  • Aged
  • Disease Progression
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Middle Aged
  • Multimodal Imaging / methods
  • Multiple Myeloma / pathology*
  • Multiple Myeloma / therapy
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Paraproteinemias / pathology
  • Paraproteinemias / therapy
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals
  • Tomography, X-Ray Computed / methods*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18